Vasomedical Looks To CMS Coverage, Trial Publication To Boost Revenue

Vasomedical is counting on CMS to issue a national coverage decision for the Lumenair EECP enhanced external counterpulsation therapy for angina and heart failure patients to help boost dwindling revenue